Aimedis
Medical tourism is emerging all over the world, with countries such as Turkey, India, Thailand, and even European countries competing to offer a variety of specialized medical treatments. This offer is ideal for patients who want quality and cost-effective medical care. This trend towards medical tourism is driven by increased access to high-quality care and services in low-cost countries or the lack of availability and affordability of care in the patient's home country. How is Aimedis strategically positioned to take advantage of this unique situation?
Not only do we establish a relationship between patients and care providers, but we also compare prices and find the best deals for patients, making it easier than ever to find the care they need. We also store and store all relevant information in patient records and link doctors who treat patients before, during and after the procedure in question. This practice ensures patient transparency within AIMChain 2.0 by making patient data incorruptible and 100% authentic. It also ensures the integrity and security of transactions and procedures for patients, improving safety and outcomes.
Ideally located in the Netherlands, Dubai and the Philippines, Aimedis has an extensive network of doctors and supporters who truly make Aimedis a key player in the healthcare environment, providing services to a growing community of empowered patients.
Aimedis offers international diagnostic and treatment correspondence according to WHO standards. Our unique solutions include seamless integration into existing healthcare IT environments and support for all major medical standards such as HIPAA compliance, IHE compatibility, ISO certification, HL7/FHIR, SNOMED, LOINC, ICD-10, ATC and more. In addition, Aimedis is already a registered medical product in the European Union. The Aimedis platform offers a complete e-health ecosystem consisting of several modules and can be extended.
The entire platform is supported by our AIMChain 2.0 blockchain secure data structure which secures all shares and information shared and accessed on Aimedis. Ecosystems will use artificial intelligence in a number of ways (see Artificial Intelligence-Supported Therapy, Diagnosis, and Research).
Aimedis is a company based in the Netherlands and UAE that provides innovative next generation healthcare solutions designed to connect patients with healthcare services and providers such as doctors, hospitals and scientific research facilities.
While competitors exist in this space, Aimedis is one of the few companies with an operational platform to integrate the latest blockchain technology alongside artificial intelligence (AI).
Aimedis is the only existing medical ecosystem that combines the knowledge of healthcare professionals with the intelligence of the patient community. The Aimedis team has been working on several e-health projects since 2009 including solutions for the pharmaceutical industry. Our experience combined with more than 12 years of clinical experience and experience in the pharmaceutical industry of the founders is an integral component of the ecosystem. An ecosystem, which benefits both patients and medical professionals.
The Aimedis Ecosystem consists of Aimedis patient-centered platform, professional platform, AIMSocial+ user content (videos and more), Aimedis Lab & Pharmacy, Medical Travel app, Aimedis notes, video chat, prescription, second opinion, appointments and Hospital Virtual Aimedis , all available on web and mobile, multilingual and web responsive. This means Aimedis is not only a fully functional combination of personal health records and electronic medical records but also combines a HIPAA/IHE compliant EMR/PHR with a fully HIPAA compliant video bridge between doctor and patient, an electronic prescription module, an electronic system module appointments, electronic learning & teaching section, medical video library, AI powered big data evaluation, AI powered pharmaceutical care, It finally provides patients not a dead data silo but a completely trustworthy solution to take their healthcare to a new level and make them the owner and director of their personal medical data.
AIMSOCIAL – DECENTRALIZED & INCENTIVED MEDICAL SOCIAL NETWORK
AIMSocial is our medical social media platform. This creates a space where patients support each other to lead happier and healthier lives. In this strong community, patients can share their experiences with disease, treatment effects, and all kinds of information about health, wellness and nutrition issues. That's where Aimedis finally combines empirical medical data with community-perceived data that brings together healthcare professionals with the intelligence of patient groups to achieve new levels of medical support and quality.
We know of a variety of chronic illnesses where in many cases people's health benefits more from talking to and learning from others who are similarly affected than they do from talking to doctors and nurses. They can share subjective experiences with therapy, medications and symptoms, as well as everyday life situations with their partner, family and environment. Learning to cope with family members with dementia is a common challenge. After diagnosis, caregivers begin to seek information and others who have dealt with the same experience for advice and knowledge. For those facing a harsh diagnosis or unexpected trauma and recovery, the peer community becomes a lifesaver to help cope with the condition and navigate through new treatments and protocols.
The impact of health information delivered via mobile applications is critical, especially in areas with poor infrastructure. Many studies report a significant reduction in HIV infection after people are informed about the risks and prevention. Education and awareness can be increased by healthcare professionals using social media platforms to reach people both near and far. Individuals who contribute useful information to others and create a community of followers will be incentivized. Building a community of responsible, supportive and caring people will be one of our main endeavors. The Aimedis Social Medical Network is also made up of medical influencers, i.e. doctors, nurses or health care specialists from other healthcare fields to support patients through videos, streaming, content and more.
AIMEDIS DATAXCHANGE – NFT MARKETPLACE MONETISING AND MAINSTREAMING MEDICAL DATA
The world's first medical and scientific NFT marketplace will finally mainstream and standardize the process of monetizing medical and scientific data and thereby open and expand this multi-trillion dollar market to the world. AImedis' unique NFT generates a simple and well-organized, always immutable, easy-to-follow dataset on the blockchain while keeping the data source anonymous and every stakeholder participating in the revenue process.
Revenues that are now quantifiable and predictable as the prices of medical and scientific data can finally be calculated, introducing a new standard of medical and scientific data. New data sources and buyers such as AI companies, space agencies, car manufacturers, medical hardware sellers, IoT providers, healthcare institutions even beyond the reach of any classic research process will participate and contribute to this unique new B2B option that will transform and improve the lives of millions of people around the world – and in outer space.
BUSINESS MODEL – VIRTUAL HOSPITAL & REHAB
Aimedis virtual hospital will make it easy and cost-effective to step into the future of hospital and practice information systems. Aimedis Virtual Hospital and Rehabilitation is an improved part of the Aimedis ecosystem and is monetized through a simple Software-as-a-Service (SAAS) model.
For hospitals and practices around the world that means:
- No expensive orientation fees
- Real time security monitoring
- No non-transparent contracts and renewal fees
- Always up to date at no extra cost when offering
- Simple per patient subscription model
AIMEDIS DIGITAL ASSET (AIMX TOKEN)- STRUCTURE, DISTRIBUTION & TOKENOMICS
ASSET T YPE: Token on Binance Smart Chain
MAXIMUM OFFER: 600,000,000 tokens
AVAILABLE FOR PURCHASE: 135,000,000 tokens
PRICE PER ASSET: 0.05 USD = 1 AIMX
10% DISCOUT : for services paid with AIMX tokens
EMISSION LEVEL: No new tokens will be minted, created or mined after the sale
Bet: 1 Bet = 200,000 AIMx. one minute. than 200k AIMx is required to participate in the staking program. Bet for 12 months, earn 12.5% interest on AIMx. Example: User A stakes 200,000 AIMx for 12 months => 12.5% Interest (25,000 AIMx Tokens). The lock-in time for staking is at least 6 months.
Burning: 2% of existing AIMx tokens are burned annually for 5 years. After that the decentralized government will decide on the continuation of the burning program.
Expenses: AIMx gives patients/users a 10% discount on services when used in payments. Healthcare providers & companies receive up to 50% discount on advertising costs on the platform, if they hold min. from 1 stake (200k AIMx). Pharmacies can access business transactions in the Aimedis ecosystem if they have min. from 1 stake (200k AIMx). Users can use AIMx to activate social medical functions.
Earnings: AIMx rewards for social medical activities (users, content creators, vloggers, influencers, moderators, surveys, focus groups); AIMx donations to Nonprofits or goodwill initiatives (Africa, Philippines, Malaysia); AIMx funding for creative projects to spread awareness (HIV/AIDS, rare diseases, etc); An advocacy program for the workplace (hospitals, clinics, pharmacies) where participants can increase their Aimedis and AIMx scores to unlock premium features (eg premium staffing services); get AIMx, perks and premium access by building local communities as Aimedis ambassadors.
Patients and data providers such as research facilities or CROs can share their data with healthcare institutions, pharmaceutical companies, and insurance companies through Aimedis' unique medical and scientific data NFT. Thus patients can also participate in medical trials that are strictly administered through the Aimedis ecosystem. Data sharing is ALWAYS voluntary and NEVER mandatory.
Patients and data providers are paid to share data via NFT. They can earn Aimedis Tokens (AIMX tokens) for sharing their data with Aimedis WITHOUT ANONYMOUS, and get % discount on services on Aimedis.
Aimedis uses ANONYMOUS shared medical data for large medical online trials – this data is ALWAYS anonymized and companies can sell this data to the pharmaceutical industry and research organizations.
AIMx rewards participants in the Aimedis social healthcare ecosystem, which includes video and chat groups, blogs, pods, and medical influencers. Rewards for participating in health companies are provided group discussions, surveys and tests. Content creators can use AIMx to enable premium features to publish their content.
Rewards for end users who choose to receive advertisements. Use AIMx for donations to healthcare nonprofits in the Aimedis ecosystem. AIMx can be used as a ticketing system to access certain AIMx social sections. Rewards for the Aimedis ambassador program to build local communities (support, elearning, focus groups, patient/doctor/nurse communities, special medical conditions i.e. diabetes community ambassadors).
Funding for online content creators, creative contests, art to spread awareness about medical conditions, to fight bias against HIV/AIDS, STDs, etc. with AIMx. A dedicated advocacy program for private hospitals to motivate and enable your hospital's medical staff to create content and demonstrate what the work environment is like, with colleagues, medical facilities, technology and equipment, and life in the hospital.
For every content created (videos, photos, blog posts, stories), your institution receives an advocacy score, while medical staff are rewarded in tokens. Advocacy scores will help to give in terms of workplace ethics, diversity, inclusion – which unlocks medical staff discounts; while medical staff can use tokens to unlock premium features. Patients & staff can also choose their favorite hospital, based on different factors.
AIMEDICAL ROADMAP UNTIL 2022
- Q1 2020 – Aimedis V2 Launched
- Q2 2020 – AIMChain 2.0 launched
- Q3 2020 – Aimedis platform registered as medical product CE certificate
- Q4 2020 – Aimedis V3 launched & app updated
- Q4 2020 – Aimedis Staff & HR launched
- Q3 2020 – Aimedis iOS & Android App released
- Q1 2021 – New Aimedis blockchain protocol and AIMx
- Q1 2021 – Aimedis lab launch
- Q2 2021 – Aimedis Virtual Hospital Launch
- From 2022 – Launch of Aimedis Social Media Network (AIMSocial)
- Q3/Q4 2021 – Aimedis eShop & Pharmacy
- Q3/Q4 2021 – Launch of Aimedis DataXChange NFT & data trading
For More Information:
Website: https://aimedis.io/aimx-nft-blockchain
WhitePaper : https://aimedis.io/static/media/AimedisWhitePaperUpdated.d752751a.pdf
Twitter : https://twitter.com/AimedisGlobal
Facebook : https://www.facebook.com/aimedisglobal
Linkedin : https://www.linkedin.com/company/aimedis/
Telegram : https://t.me/aimedisnews
Instagram : https://www.instagram.com/aimedisglobal/
Youtube : https://www.youtube.com/channel/UCRK4YOmEGst6kk54g13RK7A
Media : https://aimedisglobal.medium.com/
Author :
Bitcointalk Username: David Lopez
BitcoinTalk Profile URL: https://bitcointalk.org/index.php?action=profile;u=2853232
Telegram Username: @JonathanFrizzy
Wallet : 0x9c74d42ac4760b03ab04807a8b762fb239da783c
